To explore the function of SEC61G in breast cancer, we utilized siRNAs targeting SEC61G to knock down the expression of SEC61G in MCF-7 and MDA-MB-231 cells, which had the highest expression level of SEC61G (Fig. 3A). This evidence concerns the gene SEC61G and breast carcinoma.